JPS6025917A - ユビデカレノン固型製剤 - Google Patents
ユビデカレノン固型製剤Info
- Publication number
- JPS6025917A JPS6025917A JP13196983A JP13196983A JPS6025917A JP S6025917 A JPS6025917 A JP S6025917A JP 13196983 A JP13196983 A JP 13196983A JP 13196983 A JP13196983 A JP 13196983A JP S6025917 A JPS6025917 A JP S6025917A
- Authority
- JP
- Japan
- Prior art keywords
- ubidecarenone
- polymer
- propylene oxide
- pharmaceutical preparation
- ethylene oxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 title claims abstract description 20
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 title claims abstract description 20
- 235000017471 coenzyme Q10 Nutrition 0.000 title claims abstract description 20
- 229960004747 ubidecarenone Drugs 0.000 title claims abstract description 20
- 239000007787 solid Substances 0.000 title claims abstract description 12
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 229920001577 copolymer Polymers 0.000 claims abstract description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims description 8
- 229920000642 polymer Polymers 0.000 abstract description 13
- 238000002156 mixing Methods 0.000 abstract description 6
- 239000002775 capsule Substances 0.000 abstract description 4
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 abstract description 3
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 2
- 206010030113 Oedema Diseases 0.000 abstract description 2
- 206010037368 Pulmonary congestion Diseases 0.000 abstract description 2
- 239000002253 acid Substances 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 239000002552 dosage form Substances 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 230000009965 odorless effect Effects 0.000 abstract description 2
- 230000009967 tasteless effect Effects 0.000 abstract description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 abstract 1
- 206010019842 Hepatomegaly Diseases 0.000 abstract 1
- 239000003513 alkali Substances 0.000 abstract 1
- 238000007711 solidification Methods 0.000 abstract 1
- 230000008023 solidification Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 239000008187 granular material Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000001341 hydroxy propyl starch Substances 0.000 description 4
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- -1 fatty acid ester Chemical class 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 241000087799 Koma Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- PGZIKUPSQINGKT-UHFFFAOYSA-N dialuminum;dioxido(oxo)silane Chemical compound [Al+3].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O PGZIKUPSQINGKT-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13196983A JPS6025917A (ja) | 1983-07-21 | 1983-07-21 | ユビデカレノン固型製剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13196983A JPS6025917A (ja) | 1983-07-21 | 1983-07-21 | ユビデカレノン固型製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6025917A true JPS6025917A (ja) | 1985-02-08 |
| JPH0463851B2 JPH0463851B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1992-10-13 |
Family
ID=15070456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13196983A Granted JPS6025917A (ja) | 1983-07-21 | 1983-07-21 | ユビデカレノン固型製剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6025917A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7271209B2 (en) | 2002-08-12 | 2007-09-18 | Exxonmobil Chemical Patents Inc. | Fibers and nonwovens from plasticized polyolefin compositions |
| US7531594B2 (en) | 2002-08-12 | 2009-05-12 | Exxonmobil Chemical Patents Inc. | Articles from plasticized polyolefin compositions |
| US7622523B2 (en) | 2002-08-12 | 2009-11-24 | Exxonmobil Chemical Patents Inc. | Plasticized polyolefin compositions |
| JP2005535748A (ja) | 2002-08-12 | 2005-11-24 | エクソンモービル・ケミカル・パテンツ・インク | 可塑性ポリオレフィン組成物 |
-
1983
- 1983-07-21 JP JP13196983A patent/JPS6025917A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0463851B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1992-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI245644B (en) | Improved aqueous solubility pharmaceutical formulations | |
| JP3778948B2 (ja) | 水溶性薬物を含有する制御的放出錠剤 | |
| CA1315202C (en) | Oral sustained release acetaminophen formulation and process | |
| US5017613A (en) | Valproic acid preparations | |
| US5763493A (en) | Stabilized pharmaceutical | |
| US5348745A (en) | Aqueous granulation solution and a method of tablet granulation | |
| US6197336B1 (en) | Fast dissolving compositions having analgesic activity | |
| US4254099A (en) | Pharmaceutical tablet composition | |
| CS244909B2 (en) | Production method of retarded form of bromohexine | |
| IE64659B1 (en) | Pimobendan compositions | |
| JP2010047612A (ja) | ナテグリニド含有製剤 | |
| WO1999062499A1 (en) | Stabilized pharmaceutical compositions | |
| WO1997033568A1 (en) | Filled gelatin capsules having a reduced degree of cross-linking | |
| NO329940B1 (no) | Anvendelse av crospovidon med natriumhydroksyd for a stabilisere rabeprazol | |
| ZA200007509B (en) | Pharmaceutical preparation containing levothyroxine sodium. | |
| JP4856843B2 (ja) | 新規フェノフィブラート錠剤 | |
| KR0170380B1 (ko) | 고상 투여형용 안정화계 | |
| EP1793801A1 (en) | Novel granulation process and granulate produced therefrom | |
| JPS6025917A (ja) | ユビデカレノン固型製剤 | |
| KR20030011797A (ko) | 맛이 차폐된 과립형 입자 | |
| US4975283A (en) | Stabilized enteric coated aspirin granules and process for preparation | |
| WO2005009407A2 (en) | Oral pharmaceutical formulations of olanzapine | |
| US8062664B2 (en) | Process for preparing formulations of lipid-regulating drugs | |
| JP4379853B2 (ja) | 直接錠剤化用調合物および補助剤の調合方法 | |
| JPH08291063A (ja) | 易吸収性製剤及びその製造法 |